To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TRIB3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
246 supporting clones for gene TRIB3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK297546 brain .a 1 to 1532 2 to 1533 E358G tiling clone,   1533/1533
(100 %)
2 diff
(99.9 %id)
DA520328 brain .a 1 to 557 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
BM009555 amelanotic melanoma, cell line, skin .a 980 to 1577 1 to 597       597/597
(100 %)
4 diff
(99.4 %id)
TI_59384312   .a 980 to 1577 63 to 659       597/597
(100 %)
4 diff
(99.4 %id)
BM557568 amelanotic melanoma, cell line, skin .a 982 to 1836 1 to 862       862/1062
(81 %)
16 diff
(98.5 %id)
BE408805 choriocarcinoma, placenta .a 987 to 1624 1 to 638       638/639
(99 %)
2 diff
(99.7 %id)
BE276323 melanotic melanoma, skin .a 988 to 1689 1 to 698       698/771
(90 %)
22 diff
(97.2 %id)
ES314859 occipital scalp hair, skin .a 1023 to 1147 1 to 125       125/125
(100 %)
0 diff
(100 %id)
CB120843 cervix, Uterine .a 1033 to 1425 1 to 393       393/393
(100 %)
1 diff
(99.8 %id)
BG118523 adenocarcinoma, cell line, Liver .a 1055 to 1856 1 to 803       803/910
(88 %)
23 diff
(97.5 %id)
BG575275 breast, mammary adenocarcinoma, cell line .a 1062 to 2015 1 to 958       958/975
(98 %)
27 diff
(97.3 %id)
BE515059 adenocarcinoma cell line, ovary .a 1082 to 1714 40 to 670       631/670
(94 %)
6 diff
(99.2 %id)
CB121013 Liver .a 1109 to 1513 1 to 405       405/405
(100 %)
2 diff
(99.6 %id)
BM792151 Ascites, stomach .a 1112 to 1808 1 to 697       697/697
(100 %)
1 diff
(99.9 %id)
CN308676 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1183 to 1830 1 to 648       648/648
(100 %)
0 diff
(100 %id)
BI223610 cervical carcinoma cell line, cervix .a 1208 to 1921 1 to 729       729/781
(93 %)
27 diff
(96.6 %id)
BM757899 Ascites, stomach .a 1332 to 1840 1 to 509       509/509
(100 %)
2 diff
(99.7 %id)
BM760841 Ascites, stomach .a 1332 to 1842 1 to 511       511/511
(100 %)
2 diff
(99.7 %id)
BM749999 stomach .a 1354 to 1971 1 to 617       617/617
(100 %)
2 diff
(99.7 %id)
BM740511 stomach .a 1354 to 1888 1 to 533       533/533
(100 %)
4 diff
(99.3 %id)
BM758389 stomach .a 1354 to 1916 1 to 563       563/563
(100 %)
1 diff
(99.9 %id)
BM793405 stomach .a 1354 to 1918 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
BM836167 stomach .a 1354 to 1752 1 to 399       399/399
(100 %)
2 diff
(99.5 %id)
BP353043   .a 1354 to 1935 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP353069   .a 1354 to 1946 1 to 593   tiling clone,   593/593
(100 %)
0 diff
(100 %id)
ES307846 beard hair, skin .a 1399 to 1571 1 to 173       173/181
(95 %)
1 diff
(99.5 %id)
BM789574 stomach .a 1404 to 2030 1 to 627       627/627
(100 %)
4 diff
(99.4 %id)
BY997122   .a 1441 to 2052 12 to 623       612/623
(98 %)
6 diff
(99.1 %id)
BP430298   .a 1508 to 1842 1 to 335       335/335
(100 %)
0 diff
(100 %id)
CN308677 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1529 to 2118 1 to 590   tiling clone,   590/590
(100 %)
0 diff
(100 %id)
BE151384 head_neck .a 1589 to 1767 1 to 178       178/178
(100 %)
9 diff
(95.0 %id)
BE179144 head_neck .a 1592 to 1942 354 to 4     Submitted on the opposite strand 351/354
(99 %)
0 diff
(100 %id)
EC499555 Prostate .a 1726 to 1808 89 to 7       83/95
(87 %)
0 diff
(100 %id)
AI266397 2 pooled tumors (clear cell type), Kidney .a 1890 to 2252 368 to 6   tiling clone,   363/368
(98 %)
1 diff
(99.8 %id)
DA527042 brain .b 1 to 491 2 to 492   tiling clone, capped   491/491
(100 %)
0 diff
(100 %id)
BX426486 T cells (Jurkat cell line) .b 46 to 721 1 to 670       670/783
(85 %)
18 diff
(97.8 %id)
BX445734 T cells (Jurkat cell line) .b 46 to 1069 1 to 1016   tiling clone,   1016/1016
(100 %)
21 diff
(98.0 %id)
AJ697940   .b 49 to 254 1 to 206       206/206
(100 %)
0 diff
(100 %id)
BX324522 Neuroblastoma Cot 25-normalized .b 70 to 834 1 to 762       762/762
(100 %)
12 diff
(98.5 %id)
AJ697939   .b 97 to 243 1 to 147       147/147
(100 %)
0 diff
(100 %id)
BQ439025 large cell carcinoma, lung .b 109 to 837 1 to 732   tiling clone,   732/945
(77 %)
16 diff
(98.4 %id)
BE277802 melanotic melanoma, skin .b 180 to 610 1 to 431       431/432
(99 %)
3 diff
(99.4 %id)
BE279219 choriocarcinoma, placenta .b 180 to 722 1 to 541       541/543
(99 %)
6 diff
(98.9 %id)
BE729164 melanotic melanoma, skin .b 180 to 939 1 to 753       753/756
(99 %)
27 diff
(96.5 %id)
BF125751 melanotic melanoma, skin .b 180 to 839 1 to 652       652/670
(97 %)
10 diff
(98.6 %id)
BX324521 Neuroblastoma Cot 25-normalized .b 1579 to 2186 616 to 1   tiling clone,   616/892
(69 %)
13 diff
(98.6 %id)
AL520576 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 1 to 844 1 to 844   tiling clone,   844/844
(100 %)
8 diff
(99.1 %id)
AY247738   .c 13 to 2501 1 to 2488 exact tiling clone,   2488/2488
(100 %)
1 diff
(100.0 %id)
NM_021158.3   .c 48 to 2493 1 to 2446 exact RefSeq, AAA   2446/2446
(100 %)
0 diff
(100 %id)
CF242813 Brain glioblastoma .c 88 to 916 1 to 838       838/903
(92 %)
24 diff
(97.4 %id)
AL525857 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 129 to 1056 1 to 915       915/918
(99 %)
23 diff
(97.5 %id)
BI258147 cervical carcinoma cell line, cervix .c 205 to 1021 1 to 821       821/821
(100 %)
8 diff
(99.1 %id)
TI_57243197   .c 221 to 1016 17 to 815       799/816
(97 %)
19 diff
(97.7 %id)
DN996738 breast cancer, Mammary gland (cancer tissue) .c 223 to 1021 4 to 803       800/803
(99 %)
8 diff
(99.1 %id)
BP283534 bone marrow .c 224 to 805 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP364205 lung .c 224 to 820 1 to 598       598/598
(100 %)
3 diff
(99.5 %id)
CV572480 cornea, eye .c 232 to 877 1 to 646       646/646
(100 %)
1 diff
(99.9 %id)
AL525711 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 236 to 1232 1 to 981       981/999
(98 %)
19 diff
(98.1 %id)
BC027484 Cervix, carcinoma .c 260 to 2493 1 to 2234 Q84R available from MGC, AAA   2234/2234
(100 %)
6 diff
(99.8 %id)
BG325225 Kidney, renal cell adenocarcinoma .c 283 to 788 1 to 504       504/504
(100 %)
3 diff
(99.5 %id)
BG828172 muscle, rhabdomyosarcoma .c 344 to 1220 1 to 880   tiling clone,   880/910
(96 %)
14 diff
(98.5 %id)
BF204896 muscle, rhabdomyosarcoma .c 378 to 1006 1 to 624       624/895
(69 %)
8 diff
(99.2 %id)
BM146835 leukopheresis .c 389 to 755 1 to 367       367/367
(100 %)
3 diff
(99.2 %id)
TI_57236857   .c 396 to 1142 85 to 837       753/967
(77 %)
24 diff
(97.6 %id)
BG828963 muscle, rhabdomyosarcoma .c 405 to 1159 1 to 756       756/756
(100 %)
7 diff
(99.1 %id)
BI114808 muscle, rhabdomyosarcoma .c 405 to 1159 1 to 758       758/760
(99 %)
12 diff
(98.5 %id)
BQ683898 melanotic melanoma, cell line, skin .c 405 to 1147 10 to 751       742/932
(79 %)
15 diff
(98.4 %id)
BQ888377 epidermoid carcinoma, cell line, lung .c 412 to 1041 1 to 639       639/950
(67 %)
13 diff
(98.7 %id)
BG397691 B-cells, primary B-cells from tonsils (cell line) .c 414 to 1320 1 to 899       899/910
(98 %)
19 diff
(98.0 %id)
BG340588 B-cells, primary B-cells from tonsils (cell line) .c 414 to 1138 1 to 727       727/751
(96 %)
20 diff
(97.4 %id)
BG755971 B-cells, primary B-cells from tonsils (cell line) .c 414 to 1088 1 to 674       674/674
(100 %)
2 diff
(99.8 %id)
BP351399   .c 415 to 996 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
AW675204 cervical carcinoma cell line, cervix .c 416 to 939 1 to 524       524/525
(99 %)
7 diff
(98.7 %id)
BU183244 melanotic melanoma, cell line, skin .c 416 to 1136 1 to 725       725/734
(98 %)
16 diff
(97.9 %id)
BQ679971 melanotic melanoma, cell line, skin .c 416 to 699 1 to 284       284/285
(99 %)
1 diff
(99.7 %id)
BU153287 large cell carcinoma, lung .c 417 to 1215 1 to 804       802/849
(94 %)
17 diff
(98.0 %id)
AL555267 placenta .c 421 to 1251 1 to 829       829/829
(100 %)
9 diff
(99.0 %id)
BX405957 fetal liver, Liver .c 421 to 1402 1 to 970       970/1011
(95 %)
23 diff
(97.8 %id)
CR609787 HeLa cells Cot 25-normalized .c 422 to 2451 1 to 2030 exact     2030/2030
(100 %)
0 diff
(100 %id)
TI_57234484   .c 422 to 1137 30 to 744       715/744
(96 %)
16 diff
(97.9 %id)
BI821825 pooled brain, lung, testis .c 423 to 1411 1 to 1019       957/1024
(93 %)
39 diff
(96.2 %id)
TI_57198522   .c 423 to 1411 37 to 1055       957/1060
(90 %)
44 diff
(95.9 %id)
BM753332 Ascites, stomach .c 423 to 911 1 to 488       488/488
(100 %)
4 diff
(99.2 %id)
BM753348 Ascites, stomach .c 423 to 876 1 to 453       453/453
(100 %)
4 diff
(99.2 %id)
BM764561 Ascites, stomach .c 423 to 1002 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BM764983 Ascites, stomach .c 423 to 1041 1 to 620       620/620
(100 %)
1 diff
(99.9 %id)
BM773292 Ascites, stomach .c 423 to 869 1 to 448       448/448
(100 %)
1 diff
(99.8 %id)
BQ224844 large cell carcinoma, lung .c 424 to 1406 1 to 999       999/1053
(94 %)
37 diff
(96.5 %id)
BX443303 B cells (Ramos cell line) .c 425 to 1348 1 to 921       921/921
(100 %)
6 diff
(99.4 %id)
BG420155 Kidney, renal cell adenocarcinoma .c 428 to 1148 1 to 722       722/884
(81 %)
16 diff
(98.2 %id)
BQ949069 large cell carcinoma, lung .c 431 to 1340 1 to 919       919/957
(96 %)
32 diff
(96.7 %id)
BP282078 bone marrow .c 432 to 1018 1 to 587       587/587
(100 %)
3 diff
(99.5 %id)
BQ951388 large cell carcinoma, lung .c 433 to 1221 1 to 795       795/842
(94 %)
8 diff
(99.1 %id)
TI_57197785   .c 434 to 1030 39 to 635       597/635
(94 %)
9 diff
(98.6 %id)
BP352115   .c 436 to 1017 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
AL556690 placenta .c 437 to 1411 1 to 966       966/981
(98 %)
17 diff
(98.3 %id)
BI820474 pooled brain, lung, testis .c 439 to 1030 1 to 592       592/592
(100 %)
3 diff
(99.5 %id)
BX367265   .c 444 to 1375 1 to 926       926/939
(98 %)
21 diff
(97.8 %id)
TI_57236733   .c 444 to 1300 25 to 879       855/880
(97 %)
14 diff
(98.5 %id)
BP282519 bone marrow .c 446 to 1026 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
AL522632 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 449 to 1319 1 to 868       868/868
(100 %)
4 diff
(99.6 %id)
BG257345 embryonal carcinoma, cell line, testis .c 449 to 1244 1 to 802       802/803
(99 %)
15 diff
(98.2 %id)
BI909168 leukocyte .c 449 to 1300 1 to 850       850/851
(99 %)
9 diff
(99.0 %id)
BP282862 bone marrow .c 449 to 1030 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP350740   .c 449 to 1029 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BG420283 Kidney, renal cell adenocarcinoma .c 451 to 1221 1 to 778       778/920
(84 %)
17 diff
(98.2 %id)
BG764508 melanotic melanoma, high MDR (cell line), skin .c 451 to 1153 1 to 705       705/705
(100 %)
7 diff
(99.1 %id)
BQ931607 eye, normal pigmented retinal epithelium .c 451 to 1233 1 to 788       788/943
(83 %)
10 diff
(99.0 %id)
BP282265 bone marrow .c 451 to 1028 1 to 578       578/589
(98 %)
3 diff
(99.5 %id)
BY993652   .c 451 to 1120 6 to 676       671/676
(99 %)
11 diff
(98.4 %id)
BG761533 melanotic melanoma, high MDR (cell line), skin .c 452 to 1206 1 to 757       757/757
(100 %)
8 diff
(99.0 %id)
BG762605 melanotic melanoma, high MDR (cell line), skin .c 452 to 1102 1 to 650       650/650
(100 %)
4 diff
(99.4 %id)
BP282041 bone marrow .c 452 to 1038 1 to 587       587/587
(100 %)
2 diff
(99.7 %id)
BM045379 carcinoma, cell line, Prostate .c 453 to 1260 1 to 810       810/810
(100 %)
6 diff
(99.3 %id)
DR763361 embryonic stem .c 454 to 1213 1 to 760       760/760
(100 %)
0 diff
(100 %id)
BG470193 adenocarcinoma cell line, colon .c 455 to 1385 1 to 931       931/931
(100 %)
31 diff
(96.7 %id)
BG470123 adenocarcinoma cell line, colon .c 455 to 1331 1 to 880       880/880
(100 %)
12 diff
(98.7 %id)
BU158759 large cell carcinoma, lung .c 455 to 1266 1 to 821       821/946
(86 %)
16 diff
(98.4 %id)
BQ221959 large cell carcinoma, lung .c 455 to 1137 1 to 684       684/1135
(60 %)
8 diff
(99.3 %id)
BQ223497 large cell carcinoma, lung .c 455 to 1368 1 to 918       918/918
(100 %)
12 diff
(98.7 %id)
AW674043 cervix .c 458 to 578 1 to 122       120/122
(98 %)
1 diff
(99.2 %id)
BE792929 lung, small cell carcinoma .c 460 to 1386 1 to 922       922/989
(93 %)
36 diff
(96.4 %id)
BE298893 muscle, rhabdomyosarcoma .c 464 to 1120 1 to 653       653/712
(91 %)
11 diff
(98.5 %id)
BE294106 muscle, rhabdomyosarcoma .c 465 to 994 1 to 529       529/529
(100 %)
1 diff
(99.9 %id)
BQ928125 epidermoid carcinoma, cell line, lung .c 467 to 1279 1 to 820       820/947
(86 %)
17 diff
(98.3 %id)
BE275248 melanotic melanoma, skin .c 469 to 1274 1 to 814       814/971
(83 %)
18 diff
(98.2 %id)
BE728817 melanotic melanoma, skin .c 469 to 1257 1 to 783       783/961
(81 %)
20 diff
(98.0 %id)
BF026145 melanotic melanoma, skin .c 469 to 1198 1 to 730       730/735
(99 %)
6 diff
(99.2 %id)
BE408772 choriocarcinoma, placenta .c 472 to 1079 1 to 608       608/685
(88 %)
5 diff
(99.3 %id)
BX462244 B cells (Ramos cell line) .c 490 to 773 1 to 284       284/284
(100 %)
0 diff
(100 %id)
BG327320 Kidney, renal cell adenocarcinoma .c 491 to 1159 1 to 667       667/670
(99 %)
5 diff
(99.3 %id)
BQ216198 large cell carcinoma, lung .c 504 to 1368 1 to 866       866/873
(99 %)
4 diff
(99.6 %id)
BX325345   .c 515 to 1392 1 to 878       878/878
(100 %)
9 diff
(99.0 %id)
AW328449 cervix .c 521 to 985 8 to 472       465/472
(98 %)
6 diff
(98.8 %id)
BG165024 hypernephroma, cell line, Kidney .c 527 to 1243 1 to 706       706/937
(75 %)
22 diff
(97.7 %id)
BG171687 hypernephroma, cell line, Kidney .c 532 to 1350 1 to 819       819/838
(97 %)
22 diff
(97.4 %id)
BX421477 B cells (Ramos cell line) .c 552 to 1375 1 to 822       822/822
(100 %)
3 diff
(99.7 %id)
BQ433764 large cell carcinoma, lung .c 552 to 1350 1 to 809       809/913
(88 %)
29 diff
(96.9 %id)
AF250311   .c 554 to 1630 1 to 1083 L114V E194D K196E L198K V199K ...     1078/1083
(99 %)
4 diff
(99.7 %id)
CR457366   .c 554 to 1629 1 to 1076       1076/1077
(99 %)
3 diff
(99.8 %id)
EL733385 mixed .c 554 to 1215 1 to 662       662/662
(100 %)
3 diff
(99.6 %id)
TI_1948241364   .c 554 to 1335 138 to 927       790/1368
(57 %)
31 diff
(97.8 %id)
TI_1948241365   .c 554 to 1620 136 to 1215       1080/1246
(86 %)
61 diff
(95.2 %id)
TI_1948241632   .c 554 to 1421 139 to 1018       880/1383
(63 %)
52 diff
(96.3 %id)
TI_1948241633   .c 554 to 1448 130 to 1033       904/1249
(72 %)
30 diff
(97.6 %id)
TI_1948241881   .c 554 to 1462 146 to 1053       908/1351
(67 %)
37 diff
(97.3 %id)
TI_1948241882   .c 554 to 1466 135 to 1048       914/1221
(74 %)
16 diff
(98.7 %id)
TI_1948242127   .c 554 to 1477 141 to 1062       922/1332
(69 %)
45 diff
(96.7 %id)
TI_1948242128   .c 554 to 1418 138 to 1010       873/1253
(69 %)
28 diff
(97.8 %id)
TI_1948242130   .c 554 to 1629 1196 to 123       1074/1365
(78 %)
58 diff
(95.8 %id)
TI_1948241367   .c 576 to 1629 1166 to 123       1044/1356
(76 %)
47 diff
(96.6 %id)
BI256421 cervical carcinoma cell line, cervix .c 596 to 1417 1 to 820       820/820
(100 %)
9 diff
(99.0 %id)
BQ217691 large cell carcinoma, lung .c 599 to 1564 1 to 985       985/1036
(95 %)
38 diff
(96.4 %id)
BU500176   .c 602 to 1418 1 to 825       825/914
(90 %)
18 diff
(98.1 %id)
BM791610 stomach .c 627 to 1273 1 to 648       648/648
(100 %)
3 diff
(99.6 %id)
TI_154162972   .c 637 to 1201 80 to 640       561/684
(82 %)
10 diff
(98.6 %id)
BG331647 large cell carcinoma, lung .c 646 to 1380 1 to 732       732/851
(86 %)
13 diff
(98.5 %id)
TI_1948241884   .c 650 to 1629 1113 to 124       990/1438
(68 %)
32 diff
(97.8 %id)
BM821361 stomach .c 656 to 1154 1 to 499       499/499
(100 %)
2 diff
(99.6 %id)
BG332210 large cell carcinoma, lung .c 673 to 1394 1 to 709       709/910
(77 %)
18 diff
(98.1 %id)
CF146666 CNCAP(3)T-225 cell line, Prostate .c 725 to 1364 8 to 647       640/647
(98 %)
9 diff
(98.7 %id)
TI_154179155   .c 725 to 1515 77 to 861       785/924
(84 %)
16 diff
(98.3 %id)
AW328654 cervix .c 728 to 1191 1 to 464       464/464
(100 %)
1 diff
(99.8 %id)
TI_1948241366   .c 732 to 1629 1030 to 124       907/1204
(75 %)
34 diff
(97.2 %id)
TI_1948241634   .c 736 to 1629 1035 to 129       864/1214
(71 %)
34 diff
(97.2 %id)
TI_1948241635   .c 741 to 1629 1024 to 124       903/1470
(61 %)
39 diff
(97.4 %id)
BF309552 muscle, rhabdomyosarcoma .c 747 to 1466 1 to 715       715/878
(81 %)
17 diff
(98.1 %id)
BI255247 cervical carcinoma cell line, cervix .c 755 to 1289 1 to 535       535/535
(100 %)
3 diff
(99.5 %id)
TI_1948241883   .c 758 to 1629 1013 to 127       887/1233
(71 %)
21 diff
(98.3 %id)
CA495347   .c 768 to 1577 1 to 817       817/892
(91 %)
13 diff
(98.6 %id)
TI_59382975   .c 791 to 1528 63 to 801       739/739
(100 %)
6 diff
(99.2 %id)
BM007742 Spleen .c 792 to 1528 1 to 738       738/738
(100 %)
6 diff
(99.2 %id)
BI334267 cervical carcinoma cell line, cervix .c 831 to 1534 1 to 702       702/703
(99 %)
9 diff
(98.8 %id)
TI_1948242129   .c 891 to 1629 874 to 126       749/1305
(57 %)
25 diff
(98.1 %id)
BM743773 Ascites, stomach .c 893 to 1540 1 to 648       648/648
(100 %)
0 diff
(100 %id)
BM765164 Ascites, stomach .c 893 to 1353 1 to 461       461/461
(100 %)
0 diff
(100 %id)
BM765228 Ascites, stomach .c 893 to 1363 1 to 471       471/471
(100 %)
0 diff
(100 %id)
BM764986 Ascites, stomach .c 893 to 1578 1 to 686       686/686
(100 %)
0 diff
(100 %id)
BM781551 Ascites, stomach .c 893 to 1525 1 to 634       634/634
(100 %)
1 diff
(99.9 %id)
BM772759 Ascites, stomach .c 893 to 1537 1 to 645       645/645
(100 %)
0 diff
(100 %id)
BG422518 Kidney, renal cell adenocarcinoma .c 924 to 1634 1 to 707       707/716
(98 %)
13 diff
(98.2 %id)
BE546514 cervical carcinoma cell line, cervix .c 949 to 1746 1 to 798       798/809
(98 %)
37 diff
(95.5 %id)
TI_154170398   .c 968 to 1730 78 to 831       754/864
(87 %)
70 diff
(91.9 %id)
BG750849 eye, normal pigmented retinal epithelium .c 982 to 1670 1 to 686       686/686
(100 %)
14 diff
(98.0 %id)
CX873297 embryonic stem .c 1005 to 1724 1 to 720       720/720
(100 %)
0 diff
(100 %id)
BG325442 Kidney, renal cell adenocarcinoma .c 1006 to 1511 1 to 506       506/506
(100 %)
1 diff
(99.9 %id)
BG437266 large cell carcinoma, lung .c 1010 to 1833 1 to 841       841/915
(91 %)
39 diff
(95.8 %id)
BQ941789 large cell carcinoma, lung .c 1036 to 1891 1 to 858       858/881
(97 %)
7 diff
(99.3 %id)
AA330920 embryo .c 1039 to 1299 1 to 261       261/261
(100 %)
0 diff
(100 %id)
BF969188 adrenal cortex carcinoma, cell line, adrenal gland .c 1056 to 1473 1 to 418       418/418
(100 %)
0 diff
(100 %id)
EC466695 Prostate .c 1095 to 1188 1 to 94       94/94
(100 %)
0 diff
(100 %id)
EC539394 Prostate .c 1095 to 1188 1 to 94       94/94
(100 %)
0 diff
(100 %id)
BI254469 cervical carcinoma cell line, cervix .c 1110 to 1816 1 to 705       705/705
(100 %)
13 diff
(98.2 %id)
AA308531 colon .c 1112 to 1544 1 to 433       433/433
(100 %)
1 diff
(99.8 %id)
BX445733 T cells (Jurkat cell line) .c 1364 to 2436 1092 to 25       1068/1094
(97 %)
0 diff
(100 %id)
AL525890 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 1428 to 2455 1018 to 1       1018/1041
(97 %)
30 diff
(97.2 %id)
BX426485 T cells (Jurkat cell line) .c 1471 to 2467 990 to 1       990/1061
(93 %)
36 diff
(96.7 %id)
AL562576 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 1476 to 2432 997 to 35       963/997
(96 %)
0 diff
(100 %id)
AL578892 placenta .c 1482 to 2470 997 to 12       986/1030
(95 %)
0 diff
(100 %id)
BX367264   .c 1524 to 2488 960 to 1       960/1036
(92 %)
11 diff
(99.0 %id)
BX325344   .c 1537 to 2466 930 to 1       930/930
(100 %)
8 diff
(99.2 %id)
AL562114 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 1560 to 2437 883 to 14       870/883
(98 %)
0 diff
(100 %id)
AL520575 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 1561 to 2331 770 to 1       770/770
(100 %)
19 diff
(97.6 %id)
BX435881 B cells (Ramos cell line) .c 1584 to 2496 917 to 1       917/917
(100 %)
42 diff
(95.5 %id)
BI861766 breast, mammary adenocarcinoma, cell line .c 1588 to 2415 1 to 826       826/837
(98 %)
7 diff
(99.2 %id)
TI_57193153   .c 1588 to 2415 50 to 875       826/837
(98 %)
7 diff
(99.2 %id)
TI_154127456   .c 1598 to 2497 980 to 95   AAA   886/981
(90 %)
28 diff
(97.2 %id)
BG165080 hypernephroma, cell line, Kidney .c 1601 to 2430 1 to 814       814/976
(83 %)
42 diff
(95.7 %id)
AL555266 placenta .c 1618 to 2467 847 to 1       847/847
(100 %)
16 diff
(98.2 %id)
BM931775 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1637 to 2119 1 to 483   fully sequenced,   483/483
(100 %)
0 diff
(100 %id)
BM907602 large cell carcinoma, lung .c 1656 to 2499 870 to 15     Submitted on the opposite strand 856/1051
(81 %)
0 diff
(100 %id)
BG387820 embryonal carcinoma, cell line, testis .c 1661 to 2414 1 to 753       753/792
(95 %)
8 diff
(99.0 %id)
BQ882363 brain, neuroblastoma, cell line .c 1707 to 2499 813 to 13     Submitted on the opposite strand 801/946
(84 %)
0 diff
(100 %id)
BX405956 fetal liver, Liver .c 1720 to 2440 724 to 1       724/883
(81 %)
22 diff
(97.6 %id)
BG528789 adenocarcinoma, Prostate .c 1724 to 2487 1 to 768       768/773
(99 %)
21 diff
(97.3 %id)
BM804790 ovary (pool of 3) .c 1745 to 2492 26 to 772   AAA   747/776
(96 %)
2 diff
(99.8 %id)
TI_154065042   .c 1790 to 2499 814 to 103       712/839
(84 %)
0 diff
(100 %id)
BF038223 adenocarcinoma, ovary .c 1795 to 2371 1 to 583       583/583
(100 %)
5 diff
(99.2 %id)
BI114297 muscle, rhabdomyosarcoma .c 1808 to 2499 1 to 693       693/746
(92 %)
7 diff
(99.1 %id)
BX415397 thymus .c 1828 to 2499 1 to 672       672/672
(100 %)
1 diff
(99.9 %id)
TI_154022042   .c 1829 to 2497 757 to 89   AAA   669/670
(99 %)
1 diff
(99.9 %id)
CA438761 lung, Metastatic Chondrosarcoma .c 1854 to 2497 658 to 15   AAA   644/644
(100 %)
1 diff
(99.9 %id)
CA417146 Chondrosarcoma Cell line .c 1854 to 2497 657 to 15   AAA   643/643
(100 %)
1 diff
(99.9 %id)
BU625351 cell lines, Enchondroma .c 1908 to 2497 611 to 19   AAA   593/593
(100 %)
3 diff
(99.5 %id)
AI949781 2 pooled tumors (clear cell type), Kidney .c 1915 to 2499 586 to 2       585/586
(99 %)
0 diff
(100 %id)
BE858443 brain, glioblastoma (pooled) .c 1954 to 2498 545 to 1       545/545
(100 %)
0 diff
(100 %id)
BF431955 pooled .c 1961 to 2499 546 to 8       539/546
(98 %)
0 diff
(100 %id)
BM145678 leukopheresis .c 1971 to 2499 543 to 14       530/543
(97 %)
0 diff
(100 %id)
BM751159 Ascites, stomach .c 1990 to 2486 1 to 497       497/497
(100 %)
0 diff
(100 %id)
BP392238 pancreatic islet .c 1998 to 2497 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
BF062648 colon, colon tumor, RER+ .c 2014 to 2499 491 to 6       486/491
(98 %)
0 diff
(100 %id)
AA641038 invasive tumor (cell line), Prostate .c 2016 to 2469 455 to 1       455/455
(100 %)
3 diff
(99.4 %id)
AW328450 cervix .c 2018 to 2497 499 to 20   AAA   480/480
(100 %)
0 diff
(100 %id)
AI400049 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2048 to 2497 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AI934772 anaplastic oligodendroglioma, brain .c 2052 to 2497 446 to 1       446/446
(100 %)
0 diff
(100 %id)
AW673836 cervix .c 2058 to 2498 441 to 1       441/441
(100 %)
0 diff
(100 %id)
BM788483 Ascites, stomach .c 2060 to 2497 1 to 438   AAA   438/438
(100 %)
0 diff
(100 %id)
AI018264 pooled .c 2071 to 2499 436 to 8       429/436
(98 %)
0 diff
(100 %id)
AW261917 brain, three pooled meningiomas .c 2071 to 2497 427 to 1       427/427
(100 %)
1 diff
(99.8 %id)
AW674640 cervical carcinoma cell line, cervix .c 2071 to 2497 427 to 1       427/427
(100 %)
0 diff
(100 %id)
AI347550 2 pooled tumors (clear cell type), Kidney .c 2072 to 2497 437 to 12   AAA   426/426
(100 %)
0 diff
(100 %id)
AI591018 ovary, tumor, 5 pooled (see description) .c 2072 to 2497 426 to 1       426/426
(100 %)
0 diff
(100 %id)
AI559956 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 2081 to 2497 417 to 1       417/417
(100 %)
0 diff
(100 %id)
BF213307 bone marrow, from acute myelogenous leukemia .c 2086 to 2493 1 to 407   AAA   407/407
(100 %)
1 diff
(99.8 %id)
BM675567 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 2089 to 2497 426 to 19   fully sequenced, AAA   408/408
(100 %)
0 diff
(100 %id)
AI038198   .c 2120 to 2499 382 to 3       380/382
(99 %)
0 diff
(100 %id)
AI393047 B-cell, chronic lymphotic leukemia .c 2141 to 2496 356 to 1       356/356
(100 %)
0 diff
(100 %id)
AA837888 epithelium (cell line), Prostate .c 2152 to 2469 317 to 1       317/317
(100 %)
3 diff
(99.1 %id)
AA937898 adenocarcinoma, colon .c 2152 to 2497 345 to 1       345/345
(100 %)
2 diff
(99.5 %id)
AI419695 brain, glioblastoma (pooled) .c 2187 to 2497 311 to 1       311/311
(100 %)
1 diff
(99.7 %id)
AA379659 skin .c 2214 to 2493 1 to 280       280/280
(100 %)
0 diff
(100 %id)
AW328740 cervix .c 2239 to 2497 286 to 28   AAA   259/259
(100 %)
0 diff
(100 %id)
BP305236   .c 2262 to 2497 1 to 236   AAA   236/236
(100 %)
0 diff
(100 %id)
AA564024 colon, tumor .c 2315 to 2469 155 to 1       155/155
(100 %)
0 diff
(100 %id)
BG748142 eye, normal pigmented retinal epithelium .d 1 to 864 1 to 863 Q91R H265Q P273A V274C K279Q ... tiling clone,   863/863
(100 %)
12 diff
(98.7 %id)
BQ941036 large cell carcinoma, lung .e 1 to 877 1 to 879 Q98R K132Q V134C A135G R136S ... tiling clone,   879/881
(99 %)
7 diff
(99.3 %id)
BM453726 melanotic melanoma, skin .f 1 to 793 1 to 799 exact tiling clone,   799/884
(90 %)
14 diff
(98.5 %id)
AJ697936   Gene TRIB3, variant not shown         This clone was ignored    
AK026945   Gene TRIB3, variant not shown       available from FLJ, AAA This clone was ignored    
AK222837 Liver Gene TRIB3, variant not shown         This clone was ignored    
TI_149295305   Gene TRIB3, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI